EUVIMEDEUVIMED entdecken
Crossref

Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma

Dengqiang Lin, Jinglai Lin, Yujun Liu, Zhibing Xu, Xiaoxia Li

Clinical and Investigative Medicine · 01.03.2026 · 49 (1) · 6-15

DOI: 10.3138/cim-2025-0098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Investigative Medicine, erschienen am 01.03.2026. Verfasst von Dengqiang Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, China. Hauptthemen laut MEDLINE: Pheochromocytoma, Hemodynamics, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Pheochromocytoma (PHEO), a neuroendocrine tumour characterized by catecholamine hypersecretion, poses significant peri-operative challenges due to unpredictable intra-operative hemodynamic instability (IHI). This investigation sought to characterize clinicopathological predictors of IHI and develop a risk-stratification tool to optimize surgical management.

Methods

In this retrospective cohort study, 98 patients with histologically confirmed PHEO underwent comprehensive predictor screening via univariate and least absolute shrinkage and selection operator (LASSO) regression analyses. Cohort stratification allocated 70% (69 patients) to model development and 30% (29 patients) for validation. Predictive performance was rigorously assessed through receiver operating characteristic (ROC) analysis, bootstrap-corrected calibration curves (1,000 iterations), and decision curve methodology.

Results

Multivariable modelling identified three independent predictors of IHI: plasma normetanephrine (NMN) level (OR 1.84 [95% CI 1.04 to 3.33]), total bilirubin (TBIL; 9.75 [SD 5.36] versus 7.50 [SD 2.96] µmol/L, P < 0.05), and maximum diameter (MaxD; 5.17 [SD 2.14] versus 4.25 [SD 1.53] cm, P < 0.05). The composite nomogram demonstrated robust discriminative capacity, achieving area under curve of 0.76 (0.90 sensitivity) and 0.80 (0.73 sensitivity) in training and validation cohorts, respectively. Bootstrap validation revealed excellent calibration accuracy, while decision curve analysis confirmed superior net benefit versus NMN level-only predictions across clinical probability thresholds.

Conclusion

By integrating biochemical, anatomical, and functional parameters, this triparametric risk-stratification model enables pre-operative identification of high-risk PHEO patients, developing personalized peri-operative management strategies to mitigate catecholamine-driven complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaHemodynamicsAdrenal Gland NeoplasmsHumansFemaleRetrospective StudiesMaleRisk AssessmentMiddle AgedROC CurveAdultIntraoperative Period

Stichwörter der Autor:innen

decision curve analysis (DCA)hemodynamic instabilitynomogrampheochromocytomareceiver operating characteristic (ROC)

Autor:innen und Institutionen

  • Department of Urology, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, China.
  • Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Radiology, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, China.

Zitieren

APA

Lin, D., Lin, J., Liu, Y., Xu, Z., & Li, X. (2026). Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma. Clinical and Investigative Medicine, 49(1), 6-15. https://doi.org/10.3138/cim-2025-0098

Vancouver

Lin D, Lin J, Liu Y, Xu Z, Li X. Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma. Clinical and Investigative Medicine. 2026;49(1):6-15. doi:10.3138/cim-2025-0098

BibTeX
@article{Lin2026,
  author = {Lin, Dengqiang and Lin, Jinglai and Liu, Yujun and Xu, Zhibing and Li, Xiaoxia},
  title = {Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma},
  journal = {Clinical and Investigative Medicine},
  year = {2026},
  volume = {49},
  number = {1},
  pages = {6--15},
  doi = {10.3138/cim-2025-0098}
}
Kostenlos starten →